EU Approves OGSIVEO for Adult Desmoid Tumor Treatment
SpringWorks Therapeutics, a subsidiary of Merck KGaA based in Darmstadt, Germany, announced that the European Commission has approved OGSIVEO for adults with progressing desmoid tumors requiring medical treatment. This...